Derivates of [6, 7-dihydro - 5H - imidazo[1,2- alpha]imidazole-3-sulfonylamino]-propionamide and their use as inhibitors upon the interaction of CAMS and leukointegrins
申请人:Boehringer Ingelheim Pharmaceuticals, Inc.
公开号:EP1712553A2
公开(公告)日:2006-10-18
Derivatives of [6,7-dihydro-5H-imidazo[1,2α]imidazole-3-sulfonylamino]-propionamide of the formula I
which exhibit good inhibitory effect upon the interaction of CAMs and Leukointegrins and are thus useful in the treatment of inflammatory disease.
式 I 的[6,7-二氢-5H-咪唑并[1,2α]咪唑-3-磺酰氨基]丙酰胺的衍生物
对 CAMs 和白细胞介素的相互作用具有良好的抑制作用,因此可用于治疗炎症性疾病。